Dara Henry

Dara Henry currently serves as Chief Operating Officer at Prokarium, a position held since September 2023. Prior to this role, Dara was an Entrepreneur In Residence at Evotec from January 2022 to August 2023 and worked as an Independent Consultant in 2021, providing consulting services to biotech and venture capital clients. From October 2017 to December 2020, Dara held the position of Head of Operations & Business Development at Achilles Therapeutics Limited. During a tenure at GSK from 2008 to 2017, Dara progressed through several senior roles including Senior Director of the Immunology Innovation Fund and Senior Director of Portfolio Management & Strategy for the Immuno-Inflammation Therapy Area, overseeing significant R&D projects. Additionally, Dara began a career at Credit Suisse as an equity research analyst specializing in European biotech. Dara earned a Ph.D. and an M.Sc. in Organic Chemistry from the University of Cambridge and completed A-Levels in Chemistry, Biology, Physics, Mathematics, and Advanced Mathematics at Coleraine Academical Institution.